IN

International Isotopes IncOOTC INIS Stock Report

Last reporting period 30 Jun, 2024

Updated 22 Nov, 2024

Last price

Market cap $B

0.021

Micro

Exchange

OOTC - OTC

INIS Stock Analysis

IN

Uncovered

International Isotopes Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-14/100

Low score

Market cap $B

0.021

Dividend yield

Shares outstanding

514.89 B

International Isotopes, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt tele therapy sources, as well as radioisotopes and radiochemical for medical research and clinical devices. The company is headquartered in Idaho Falls, Idaho and currently employs 30 full-time employees. Its segments include Nuclear Medicine Standards, which consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging, patient positioning, and calibration or operational testing of dose-measuring equipment for the nuclear pharmacy industry; Cobalt Products, which includes management of a cobalt irradiation contract, fabrication of cobalt capsules for teletherapy or irradiation devices, and recycling of expended cobalt sources; Radiochemical Products, which includes production and distribution of Iodine-131 generic drug product and isotopically pure radiochemicals; Fluorine Products, which is involved in the production of small-scale qualification samples of high purity fluoride gas, and Radiological Services, which consists of gemstone processing and source disposal services.

View Section: Eyestock Rating